Clinical Trials Logo

Pregnancy clinical trials

View clinical trials related to Pregnancy.

Filter by:

NCT ID: NCT02043509 Completed - Pregnancy Clinical Trials

MiQuit Trial: Tailored Text Messages for Pregnant Women

MiQuit
Start date: February 2014
Phase: N/A
Study type: Interventional

The overall aim of the study is to estimate the likely impact of the MiQuit text message based smoking cessation service for pregnant smokers and to establish robust estimates for the key factors which would be required in order to design a larger definitive trial of this intervention(MiQuit). These key factors include: the range of recruitment rates in different centres; quit rates amongst participants; feasibility of assessing smoking status of participants in later pregnancy; and the likely effect of MiQuit when women are offered this in National Health Service (NHS) settings.

NCT ID: NCT02039362 Completed - Pregnancy Clinical Trials

Prevention of Hepatitis B Virus Vertical Transmission by Serovaccination and Tenofovir During Pregnancy

Start date: July 2012
Phase: Phase 4
Study type: Interventional

The risk of vertical HBV transmission is related to HBV DNA level in pregnant women, around 30% in women with HBV DNA above 1, 000 000 I.U/mL despite serovaccination of newborns. Using tenofovir DF during the last trimester of pregnancy allows to reduce the risk, but data from Western countries are needed.

NCT ID: NCT02038023 Completed - Pregnancy Clinical Trials

Intravaneous Iron(1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes) for Pregnant Women

Start date: July 2013
Phase: Phase 2
Study type: Interventional

To determine the percentage of women who achieve anemia correction after a single dose of 1000mg of low molecular weight iron dextran(infed).

NCT ID: NCT02035059 Completed - Pregnancy Clinical Trials

Predictability of Gestational Diabetes Mellitus in First and Second Trimester

GDMPredict
Start date: May 1, 2014
Phase:
Study type: Observational

The objective of the study is, if an early oral glucose tolerance test combined with maternal history, condition and multiple biomarker analysis can be used to detect gestational diabetes mellitus in the first trimester (12-14 weeks of gestation).

NCT ID: NCT02032459 Completed - Pregnancy Clinical Trials

Vitamin D and Pregnancy: Camden Study

Start date: April 2007
Phase: N/A
Study type: Observational

Vitamin D is present in food either naturally or by fortification and included in nutritional supplements. It is also synthesized photochemically by the skin from ultraviolet B radiation. Vitamin D synthesis varies by season and with latitude as well as according to intensity of skin pigmentation. Recent research in the United States found lower circulating levels of 25 (OH) D, the primary indicator of vitamin D status, among minority women who were either pregnant or in their reproductive years. The extent to which maternal vitamin D has an influence on the course and outcome of human pregnancy remains to be more completely studied. We propose to use the HPLC method to assay cholecaliferol (vitamin D3) and ergocalciferol (vitamin D2) to assess maternal vitamin D status. This will be accomplished by analyzing existing fasting samples and data derived from the 2001-2006 cohort (N=1141) of young, low income minority gravidae from Camden, New Jersey to determine: 1. The prognostic importance of maternal vitamin D status for birth weight, gestation duration and poor pregnancy outcomes (low birth weight, preterm delivery, fetal growth restriction). 2. The relation of maternal vitamin D status to important complications of pregnancy (gestational diabetes and pre-eclampsia). 3. The relationship of maternal vitamin D status to maternal diet and supplement use, season of year, ethnicity, overweight/obesity, and other maternal characteristics.

NCT ID: NCT02029859 Completed - Obesity Clinical Trials

Sleep Apnea, Obesity and Pregnancy

GOS
Start date: April 2011
Phase: N/A
Study type: Interventional

Main objective: Determine the prevalence of obstructive sleep apnea syndrome (OSA) in late pregnancy in a population of obese patients . Secondary objectives : - Identify risk factors for OSA during pregnancy (age, parity, high blood pressure, snoring , weight, neck circumference, scores on symptoms of sleep apnea, ... ) . - Compare perinatal morbidity among obese patients with OSA in late pregnancy with case-controls. - Evaluate the evolution of a moderate or severe OSA 6 months after pregnancy. Material and methods Characteristics of the study: - Interventional biomedical research - Prospective Multicenter nonrandomized study Flow chart - Patients will be included between 30 and 36 weeks of amenorrhea (WA) . - Will rated from inclusion: age, parity, weight, height, BMI in early pregnancy, neck circumferrence, treated high blood pressure. - As recommended in France, the main test results during the pregnancy follow-up will be recorded. - At the inclusion visit will be conducted a Berlin Questionnaire and Epworth Score. - Screening for OSA by nocturnal polysomnography will be performed between 30 and 36WA. This screening can be performed as an outpatient. - In case of proven OSA patients will be offered an appropriate care by today's standards. - Whatever the outcome of pregnancy, a second polysomnography will be performed 6 months after childbirth in case of OSA during pregnancy.

NCT ID: NCT02021799 Completed - Pregnancy Clinical Trials

The Effect of Under-nutrition on the Human Microbiota

Start date: August 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a difference exists in the gut, oral, vaginal and human milk microbiome of under-nourished pregnant women as compared to healthy and obese pregnant women. In addition, the investigators are setting out to determine if a micronutrient enriched probiotic yogurt can improve the microbiome and pregnancy outcomes of under-nourished pregnant women.

NCT ID: NCT02018640 Completed - Cancer Clinical Trials

Biomarker Feedback to Motivate Tobacco Cessation in Pregnant ALaska Native Women: Phase 2

MAW Phase 2
Start date: December 2013
Phase: N/A
Study type: Observational

Use of tobacco is very high among Alaska Native pregnant women. The investigators are conducting a three phase study. The first study is nearly completed and involved measuring biomarkers of tobacco exposure in mothers and infants. The second phase of the research is a qualitative study to translate the biomarker findings to an intervention.

NCT ID: NCT02016495 Completed - Pregnancy Clinical Trials

Efficacy of Magnesium and Alpha Lipoic Acid Supplementation in Reducing Premature Uterine Contractions

Start date: n/a
Phase: Phase 4
Study type: Interventional

To evaluate whether a combined supplementation of magnesium and lipoic acid is able to significantly reduce the incidence of uterine contractions and related episodes of hospitalization in pregnant women.

NCT ID: NCT02009046 Completed - Pregnancy Clinical Trials

Randomized Evaluation of a Multi-Component, Rights-Based Sexuality Education Initiative for High School Students

SEI
Start date: September 2011
Phase: N/A
Study type: Interventional

This study examines the effectiveness of the Sexuality Education Initiative (SEI), a comprehensive, multi-component, rights-based sexuality education program developed and implemented by Planned Parenthood Los Angeles for high school students. The primary goal of the SEI is to improve the sexual and reproductive health of youth attending Los Angeles high schools. The SEI consists of four intervention components: (1) a 12-session gender-sensitive, rights-based, comprehensive sexuality education curriculum, (2) a peer education and advocacy component, (3) a parent education component, and (4) clinical services linkages. It is hypothesized that the 12-session classroom curriculum is more effective than a 3-session control sex education curriculum. It is also hypothesized that the full SEI package (all four components) is more effective than the control condition (control curriculum and clinical services only).